Madhusnuhi Rasayana: Benefits, Evidence & Safety

TL;DR

Madhusnuhi Rasayana is a classical Ayurvedic avaleha (herbal jam) of 32 ingredients, Smilax china root, purified guggulu, purified sulfur, 25 herbs, ghee, sugar, and honey, traditionally used for skin diseases, gout, and nonhealing wounds. A 2025 mouse study found no acute or 28-day toxicity; human efficacy trials do not exist. (52 words. Sources: Ayurvedic Formulary of India Part I; Journal of Advanced Health Research & Clinical Medicine 2025.)

What it is

Madhusnuhi Rasayana (also spelled Madhusnuhi Rasayanam) is a classical Ayurvedic avaleha, a semisolid herbal jam, of the Kerala tradition, prepared by the Sahasrayogam method. There are two traditional variants, "cheriya" (smaller) and "valiya" (larger) Madhusnuhi Rasayana. The formulation is documented in the Ayurvedic Formulary of India (AFI) Part I, and its quality specifications are assessed against the Ayurvedic Pharmacopoeia of India Part II (Formulations). (JHCR preclinical evaluation, 2025)

Composition (per AFI Part I)

The formulation is built around the root/rhizome of Madhusnuhi (Smilax china, also called China root), with 25 powdered herbs at 6 g each, three bulk ingredients at 192 g each, and a ghee–sugar–honey base:

A 2025 peer-reviewed preclinical paper independently confirms this same roster, Emblica officinalis, Zingiber officinale, Piper longum, Piper nigrum, Terminalia bellirica, Terminalia chebula, Elettaria cardamomum, Cinnamomum zeylanicum, Cuminum cyminum, Cinnamomum tamala, Foeniculum vulgare, Nigella sativa, Piper cubeba, Embelia ribes, Saussurea costus, Operculina turpethum, Piper sylvaticum, Withania somnifera, Clerodendrum serratum, Celastrus paniculatus, Mesua ferrea, Commiphora wightii, Smilax china, clarified butter, sugar, and purified sulfur, prepared by the Sahasrayogam method with purification of S. china (boiled in cow's milk), guggulu (clarified with Curcuma zedoaria and Azadirachta indica, boiled in butter), and sulfur. (JHCR, 2025)

Traditional use

The 2025 review describes Madhusnuhi Rasayana as "a well-known preparation in Ayurveda used for skin diseases, rheumatoid arthritis, goiter, gout, and nonhealing wounds." In the classical framework it is classed as a rasayana, a rejuvenative preparation, with blood-purifying (raktashodhana) intent, consistent with its sulfur, guggulu, and Smilax china core. These are traditional indications; no clinical trials have tested whether it works for any of them. (JHCR, 2025)

What modern research says

Acute toxicity in mice (animal study)

Following OECD guideline 423, researchers gave a single oral dose of 2000 mg/kg of Madhusnuhi Rasayana to female Swiss albino mice and monitored them for 14 days. The animals remained active with no drowsiness, sedation, diarrhea, or changes in skin, hair, or eyes; there was no significant body-weight loss, no deaths, and no adverse organ findings at necropsy. The LD50 was above 2 g/kg body weight. This is a single-dose safety test in mice, not evidence of safety in humans. (JHCR, 2025)

28-day repeated-dose toxicity in mice (animal study)

The same team gave 200, 300, and 400 mg/kg orally for 28 days to male and female mice. Body weight and feed/water intake showed no significant changes between groups; hematology was mostly unchanged (small reductions in mean corpuscular volume and white-cell count in some male groups, but within the normal range for the strain). Renal markers, bilirubin, and serum protein were unchanged; liver enzymes (SGOT, SGPT) varied statistically but stayed within normal range; organ weights showed no significant variation; and histology revealed no structural damage. The authors concluded the tested doses were nontoxic in mice. Again: animal safety data, not human proof. (JHCR, 2025)

Quality and heavy-metal testing (laboratory)

Three independently prepared batches met the Ayurvedic Pharmacopoeia's organoleptic and physicochemical specifications. Cadmium was below the detection level and lead was within the permissible limit; after 28 days of dosing, lead in mouse liver and kidney tissue was below detection, indicating no accumulation. One deviation: total aerobic and yeast/mold counts were marginally above the pharmacopoeial limits, which the authors attributed to suboptimal storage and lack of preservatives. (JHCR, 2025)

Efficacy: no studies exist

The 2025 paper states plainly that "there is not much systematic study or scientific literature available using MR" for its effects. No human efficacy trials of Madhusnuhi Rasayana were found. The traditional indications (skin disease, gout, wounds) therefore have no clinical confirmation whatsoever.

Safety & contraindications

FAQs

What is Madhusnuhi Rasayana?

It is a classical Ayurvedic avaleha (semisolid herbal jam) of about 32 ingredients, built around Madhusnuhi (Smilax china) root, purified guggulu, and purified sulfur, with 25 herbs plus ghee, sugar, and honey. Two traditional variants exist: cheriya and valiya. It is documented in the Ayurvedic Formulary of India Part I. (AFI Part I composition; JHCR, 2025)

What is Madhusnuhi Rasayana traditionally used for?

Classical Ayurvedic practice uses it for skin diseases, rheumatoid arthritis, goiter, gout, and nonhealing wounds, as a rejuvenative (rasayana) and blood-purifying preparation whose sulfur, guggulu, and Smilax china core drive its traditional rationale. These are traditional indications: no clinical trials have confirmed any of them. (JHCR, 2025)

Is Madhusnuhi Rasayana safe?

The best available evidence is a 2025 mouse study: a single 2000 mg/kg dose caused no deaths or organ damage over 14 days, and 28 days of dosing at 200–400 mg/kg produced no significant organ or blood abnormalities. That is reassuring animal data, not human proof: no human safety or efficacy trials exist. It contains purified sulfur and a sugar base, so quality, diabetes, and pregnancy cautions apply. (JHCR, 2025)

Does it contain heavy metals?

It contains purified sulfur (shuddha gandhaka) as an intentional mineral ingredient: that is the formulation's main safety question. In the batches tested in the 2025 study, cadmium was below detection and lead within permissible limits, with no lead accumulation in mouse tissues. Commercial products vary, so choose manufacturers that publish heavy-metal testing. (JHCR, 2025)

Can people with diabetes take it?

With caution and medical advice. Each batch contains 576 g of sugar candy and 768 g of honey in its base, so it is a sugar-containing medicine that could affect blood glucose. Discuss it with your clinician rather than self-prescribing. (AFI Part I composition)

What is the difference between cheriya and valiya Madhusnuhi Rasayana?

They are the two traditional variants of the formulation recognized in the Kerala Ayurvedic tradition: "cheriya" (smaller) and "valiya" (larger). The 2025 preclinical paper studied the standard preparation; detailed comparative documentation of the two variants in English-language sources is sparse, so a practitioner familiar with the Sahasrayogam tradition is the best guide. (JHCR, 2025)

Sources

Tier 1 — formulary, peer-reviewed journals

This article is for educational purposes only and is not medical advice. Consult a qualified practitioner before using any Ayurvedic preparation, especially if you are pregnant, nursing, managing diabetes, or taking prescription medicines.